Schrem H - Search Results

1

Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.

Schrem H, Schneider V, Kurok M, Goldis A, Dreier M, Kaltenborn A, Gwinner W, Barthold M, Liebeneiner J, Winny M, Klempnauer J, Kleine M. Schrem H, et al. PLoS One. 2016 Jul 11;11(7):e0158732. doi: 10.1371/journal.pone.0158732. eCollection 2016. PLoS One. 2016. PMID: 27398803 Free PMC article.

2

[What's new in hepatobiliary surgery?].

Schrem H, Schütze S, Klempnauer J. Schrem H, et al. Zentralbl Chir. 2001 Aug;126(8):569-70. doi: 10.1055/s-2001-16575. Zentralbl Chir. 2001. PMID: 11518993 German. No abstract available.

3

Liver transplantation today.

Klempnauer J, Schrem H, Becker T, Nashan B, Lück R. Klempnauer J, et al. Among authors: schrem h. Transplant Proc. 2001 Nov-Dec;33(7-8):3433-5. doi: 10.1016/s0041-1345(01)02480-0. Transplant Proc. 2001. PMID: 11750470 No abstract available.

4

Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression.

Schrem H, Klempnauer J, Borlak J. Schrem H, et al. Pharmacol Rev. 2002 Mar;54(1):129-58. doi: 10.1124/pr.54.1.129. Pharmacol Rev. 2002. PMID: 11870262 Review.

5

[Living kidney transplantation. A comparison of Scandinavian countries and Germany].

Lück R, Schrem H, Neipp M, Nashan B, Klempnauer J. Lück R, et al. Among authors: schrem h. Chirurg. 2003 Jun;74(6):523-9. doi: 10.1007/s00104-003-0691-x. Chirurg. 2003. PMID: 12883801 German.

6

Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation.

Schrem H, Klempnauer J, Borlak J. Schrem H, et al. Pharmacol Rev. 2004 Jun;56(2):291-330. doi: 10.1124/pr.56.2.5. Pharmacol Rev. 2004. PMID: 15169930 Review.

7

Update on liver transplantation using cyclosporine.

Schrem H, Lück R, Becker T, Nashan B, Klempnauer J. Schrem H, et al. Transplant Proc. 2004 Nov;36(9):2525-31. doi: 10.1016/j.transproceed.2004.10.023. Transplant Proc. 2004. PMID: 15621081 Review.

8

Large-scale isolation of human hepatocytes for therapeutic application.

Alexandrova K, Griesel C, Barthold M, Heuft HG, Ott M, Winkler M, Schrem H, Manns MP, Bredehorn T, Net M, Vidal MM, Kafert-Kasting S, Arseniev L. Alexandrova K, et al. Among authors: schrem h. Cell Transplant. 2005;14(10):845-53. doi: 10.3727/000000005783982530. Cell Transplant. 2005. PMID: 16454359 Free article.

9

Sinusoidal obstruction syndrome of the liver after hematopoietic stem cell transplantation: decision making for orthotopic liver transplantation.

Koenecke C, Kleine M, Schrem H, Krug U, Nashan B, Neipp M, Ganser A, Hertenstein B, Klempnauer J. Koenecke C, et al. Among authors: schrem h. Int J Hematol. 2006 Apr;83(3):271-4. doi: 10.1532/IJH97.NA0511. Int J Hematol. 2006. PMID: 16720562

10

Physiological incompatibilities of porcine hepatocytes for clinical liver support.

Schrem H, Kleine M, Borlak J, Klempnauer J. Schrem H, et al. Liver Transpl. 2006 Dec;12(12):1832-40. doi: 10.1002/lt.20918. Liver Transpl. 2006. PMID: 17133583 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page